3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
7
Cisplatin
6
Oxaliplatin
5
Fluorouracil
4
lenvatinib
3
envafolimab
3
S 1 (combination)
3
Capecitabine
3
toripalimab
2
pembrolizumab
2
Leucovorin
2
Irinotecan
2
Folfox protocol
2
tislelizumab
1
tegafur-gimeracil-oteracil
1
surufatinib
1
pertuzumab
1
mitazalimab
1
durvalumab
1
disitamab vedotin
1
camrelizumab
1
anlotinib
1
Simvastatin
1
Self Expandable Metallic Stents
1
Bevacizumab
1
Albumin-Bound Paclitaxel
1
Actigraphy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Biliary Tract Neoplasms
×
mitazalimab
×
Clear all
NCT07437287
2026-02-27
CROCOBIL
UNICANCER
Phase 2/3
Not yet recruiting
160 enrolled